To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
To compare the safety and pharmacokinetic properties between the administration of DWP16001
and DWC202213 as an individual drug, and the administration of DWJ1563 as a combination drug.